Learn More
Medchemexpress LLC Cucurbitacin IIa | 58546-34-2 | 562.73 | 1 ML

Supplier: Medchemexpress LLC HYN198810MM/1ML
Cucurbitacin IIa, also known as Hemslecin A, is an orally active and blood-brain barrier-permeable EGFR inhibitor, demonstrating an IC50 of 1.455 nM against human EGFR. It plays a role in inducing caspase-3-dependent apoptosis, downregulating survivin expression, and enhancing autophagy levels. This compound disrupts the actin cytoskeleton through actin aggregation, arrests the cell cycle at the G2/M phase, and provides anti-inflammatory effects by inhibiting the EGFR-MAPK signaling pathway.
- Orally active, blood-brain barrier-permeable EGFR inhibitor
- Induces caspase-3-dependent apoptosis
- Downregulates survivin expression
- Enhances autophagy levels
- Disrupts actin cytoskeleton via actin aggregation
- Arrests cell cycle at G2/M phase
- Exerts anti-inflammatory activity by inhibiting EGFR-MAPK signaling pathway
- Suitable for research in inflammation-related diseases, depression, and cancers
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.